MoonLake Immunotherapeutics (MLTX) Sector Health Care
(Current)
$46.02 0.49 (1.08%)
Open Price: 46.02
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients